EFLUMENIBEP ALFA

UNII:	S9CR2ZV5Z4
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	EFLUMENIBEP ALFA
GSRS Full Record:	S9CR2ZV5Z4 i

2418159-10-9
DS-2325A
Eflumenibep Alfa
eflumenibep alfa [INN]
human serine protease inhibitor Kazal-type 2 (SPINK2, huSI-II, acrosin-trypsin inhibitor, Uniprot: P20155) (6-66 in the current sequence), variant(1DDDGP5>added, S14>L19 , 16YRLPG20> 21WTDHQ 25, 22>E27,24HFN26> 29DYD31) fused at the C-terminus to human immunoglobulin G1(IgG1) Fc fragment (h-CH2-CH3-CHS domains) (67-298) [Homo sapiens IGHG1*03 (hinge (67-81), CH2 (82-191), CH3 (192-296), CHS (297-298))], homodimer (71-71':77-77':80-80')-trisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EFLUMENIBEP ALFA

Synonyms and Mappings

Resources